Flash Therapeutics, a French CDMO specialized in the bioproduction of viral vectors for the transfer of genetic material, is expanding its collaboration with the CEA, in particular, l’Institut de biologie François Jacob – Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse (LGRK).
 
The LGRK has been sourcing specific products from Flash Therapeutics for over 10 years to support its research activities, in particular, to study the intrinsic properties and regenerative capacity of skin stem cells.
 
Now, Flash Therapeutics and the CEA’s Institut de biologie François Jacob are currently discussing expanding their partnership, given their complementary nature.
 
Jérôme Bédier, CEO of Flash Therapeutics, said: “We are delighted to be partnering with the CEA, the leading French and European player in the field of energy and technology. This approach builds on more than 10 years of collaboration and is in line with Flash’s key mission: to discover and bring forward innovative technologies for highly effective therapies on a commercial scale.”